FIELD: medicine.
SUBSTANCE: invention concerns medical equipment, namely to endoluminal prostheses, such as a coronary stent. The stent for implantation at least partially, in a blood vessel in contact to a blood vessel wall, contains at least one released medical agent. The released medical agent contains melatonin or a medical product received from the melatonin. The medical agent is applied on the surface of a stent which does not have coverings.
EFFECT: invention provides prevention of an inflammation caused by a trauma, caused at the expense of stent implantation; the prevention neointimal proliferation of a tissue and growing in a tissue; controlled remission completely a biocompatible medical product in a current of several weeks.
6 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| LOCAL VASCULAR DELIVERY OF PROBUCOL, ALONE OR IN COMBINATION WITH SIROLIMUS, FOR TREATMENT OF RESTENOSIS, VULNERABLE PLAQUES, AAA (ABDOMINAL AORTA ANEURISM) AND STROKE | 2008 |
|
RU2481084C2 |
| DEVICE FOR LOCAL AND/OR REGIONAL DELIVERY USING LIQUID FORMULATIONS OF THERAPEUTICALLY ACTIVE SUBSTANCES | 2009 |
|
RU2596092C2 |
| DEVICE FOR LOCAL AND/OR REGIONAL DELIVERY USING LIQUID FORMULATIONS OF ACTIVE SUBSTANCES | 2009 |
|
RU2513153C2 |
| LOCAL VASCULAR DELIVERY OF mTOR INHIBITORS IN COMBINATION WITH PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR STIMULATORS | 2008 |
|
RU2510654C2 |
| STENT WITH DOUBLE DRUG RELEASE | 2010 |
|
RU2552086C2 |
| RAPAMICIN-RELEASING STENT | 2010 |
|
RU2563429C2 |
| BARE METAL STENT WITH MEDICATION-RELEASING RESERVOIRS | 2011 |
|
RU2573107C2 |
| PHARMACEUTICAL COMPOSITIONS | 2004 |
|
RU2363497C2 |
| NOVEL SPECIFIC MECHANISM FOR INHIBITION OF PLATELET ADHESION TO COLLAGEN | 2001 |
|
RU2302880C2 |
| STENOSIS TREATMENT | 2018 |
|
RU2829274C2 |
